HSP90 inhibition sensitizes head and neck cancer to platin-based chemoradiotherapy by modulation of the DNA damage response resulting in chromosomal fragmentation

Peer Review reports

Original Submission
3 Aug 2016	Submitted	Original manuscript
15 Oct 2016	Reviewed	Reviewer Report - Tim Beck
21 Oct 2016	Reviewed	Reviewer Report - Anna Gaponova
21 Dec 2016	Author responded	Author comments - Martin McLaughlin
Resubmission - Version 2
21 Dec 2016	Submitted	Manuscript version 2
Publishing
23 Jan 2017	Editorially accepted
31 Jan 2017	Article published	10.1186/s12885-017-3084-0

Back to article page